Third Dose of COVID-19 Vaccine in LTCF Residents

Conditions:   SARS-CoV2 Infection;   Coronavirus Infection Interventions:   Drug: MRNA-1273;   Drug: Avaxim Sponsor:   Mark Loeb Not yet recruiting

Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials